Quantcast
Home > Quotes > BCLI

Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Quote & Summary Data

BCLI 
$3.75
*  
0.05
1.35%
Get BCLI Alerts
*Delayed - data as of Nov. 15, 2019  -  Find a broker to begin trading BCLI now
Exchange:NASDAQ
Industry: Health Care
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
12
Today's High / Low
$ 3.78 / $ 3.68
Share Volume
38,365
50 Day Avg. Daily Volume
48,525
Previous Close
$ 3.70
52 Week High / Low
$ 4.50 / $ 2.92
Market Cap
84,774,345
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.06

Intraday Chart

Shares Traded

Share Volume:
38,365
50 Day Avg. Daily Volume:
48,525

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.98

Trading Range

The current last sale of $3.75 is 28.42% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.78 $ 4.50
 Low: $ 3.68 $ 2.92

Company Description (as filed with the SEC)

· Brainstorm Cell Therapeutics Inc. is a leading biotechnology company committed to the development and commercialization of best-in-class autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis ("ALS", also known as Lou Gehrig's disease); Progressive Multiple Sclerosis ("PMS"); and Parkinson's disease ("PD"). · NurOwn® leverages proprietary cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. · Our wholly-owned Israeli subsidiary, Brainstorm Cell Therapeutics Ltd.  ... More ...  



Risk Grade

Where does BCLI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.78
Open Date:
Nov. 15, 2019
Close Price:
$ 3.75
Close Date:
Nov. 15, 2019


Consensus Recommendation

Analyst Info